ArticleDrug design, development and therapy2018

Preclinical pharmacokinetics, interspecies scaling, and pharmacokinetics of a Phase I clinical trial of TTAC-0001, a fully human monoclonal antibody against vascular endothelial growth factor 2.

Weon Sup Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.